Evotec to collaborate with Takeda on CNS discovery

Evotec AG has announced plans to collaborate with Takeda Cambridge Ltd, a unit of Japan’s largest pharmaceutical company, to identify small-molecule modulators against GPCR and protease targets involved in neurological and metabolic diseases.